Joint statement from the Faculty of Intensive Care Medicine and Intensive Care Society

7 December 2020

The Faculty of Intensive Care Medicine (FICM) and Intensive Care Society (ICS) have released a joint statement on Tociluzimab – clarification on use in critically ill patients with COVID-19. The statement can be found on both the ICS and FICM websites.

ENDS